Your browser doesn't support javascript.
loading
LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial.
Masmiquel, L; Leiter, L A; Vidal, J; Bain, S; Petrie, J; Franek, E; Raz, I; Comlekci, A; Jacob, S; van Gaal, L; Baeres, F M M; Marso, S P; Eriksson, M.
Afiliação
  • Masmiquel L; Endocrinology and Nutrition Department, Hospital Son Llàtzer, University Institute of Health Science Research (IUNICS-IdISPa), Universitat de les Illes Balears, Palma, Majorca, Spain. lmasmiquel@gmail.com.
  • Leiter LA; Divisions of Endocrinology and Metabolism, Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. leiterl@smh.ca.
  • Vidal J; Endocrinology and Nutrition Department, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. JOVIDAL@clinic.ub.es.
  • Bain S; Institute of Life Science, Swansea University, Swansea, UK. S.C.Bain@swansea.ac.uk.
  • Petrie J; Institute of Cardiovascular and Medical Science, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. John.Petrie@glasgow.ac.uk.
  • Franek E; Mossakowski Medical Research Centre, Polish Academy of Sciences and Central Clinical Hospital MSW, Warsaw, Poland. Edward.Franek@cskmswia.pl.
  • Raz I; Diabetes Unit, Internal Medicine Division, Hadassah Hebrew University Hospital, Jerusalem, Israel. ntv502@netvision.net.il.
  • Comlekci A; Department of Internal Medicine, Division of Endocrinology, Inciralti, Izmir, Turkey. comlekci@deu.edu.tr.
  • Jacob S; Praxis für Prävention und Therapie, Kardio Metabolischen Instituts, Villingen-Schwenningen, Germany. prof.dr.jacob@web.de.
  • van Gaal L; Department of Endocrinology, Diabetology, and Metabolism, Faculty of Medicine, Antwerp University Hospital, Edegem, Antwerp, Belgium. Luc.Van.Gaal@uza.be.
  • Baeres FM; Novo Nordisk, Copenhagen, Denmark. FMMB@novonordisk.com.
  • Marso SP; Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Steven.marso@utsouthwestern.edu.
  • Eriksson M; Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden. Mats.Eriksson@ki.se.
Cardiovasc Diabetol ; 15: 29, 2016 Feb 10.
Article em En | MEDLINE | ID: mdl-26864124
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Síndrome Metabólica / Diabetes Mellitus Tipo 2 / Obesidade Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cardiovasc Diabetol Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Síndrome Metabólica / Diabetes Mellitus Tipo 2 / Obesidade Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cardiovasc Diabetol Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha